+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Solid Tumor Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Solid Tumor Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Myeloproliferative Disorders Drugs Global Market Report 2024 - Product Thumbnail Image

Myeloproliferative Disorders Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Histoplasmosis Treatment Global Market Report 2024 - Product Thumbnail Image

Histoplasmosis Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Multiple System Atrophy (MSA) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Multiple System Atrophy (MSA) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 180 Pages
  • Global
From
Human Coagulation Factor IX Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Human Coagulation Factor IX Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 119 Pages
  • Global
From
Recombinant Antihemophilic Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Recombinant Antihemophilic Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 93 Pages
  • Global
From
Recombinant Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Recombinant Factor VIII Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 96 Pages
  • Global
From
Spinal Muscular Atrophy Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Spinal Muscular Atrophy Treatment Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Asia Pacific Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 87 Pages
  • Asia Pacific
From
North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 76 Pages
  • North America
From
LAMEA Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 86 Pages
  • Middle East, Africa
From
Europe Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel, By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 86 Pages
  • Europe
From
Gene Therapy Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

Gene Therapy Global Market Opportunities and Strategies to 2032

  • Report
  • April 2023
  • 305 Pages
  • Global
From
Anti-CD20 antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD20 antibody - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Protein Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Protein Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2024
  • 89 Pages
  • Global
From
Central Nervous System Therapeutic Market Size, Share & Trends Analysis Report by Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases), by Region, and Segment Forecasts, 2021-2028 - Product Thumbnail Image

Central Nervous System Therapeutic Market Size, Share & Trends Analysis Report by Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases), by Region, and Segment Forecasts, 2021-2028

  • Report
  • February 2021
  • 120 Pages
  • Global
From
Cell and Gene Therapy World Market and Market Potential - Product Thumbnail Image

Cell and Gene Therapy World Market and Market Potential

  • Report
  • February 2022
  • 272 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
AR/VR based Healthcare Digital Marketing Service Providers Market, 2020-2030 - Product Thumbnail Image

AR/VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

  • Report
  • June 2020
  • 190 Pages
  • Global
From
Amyotrophic Lateral Sclerosis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Loading Indicator